Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: A pilot study
PURPOSE: To investigate the efficacy and safety of subconjunctival bevacizumab injection for the treatment of impending recurrent pterygium. METHODS: A prospective, randomized, single-masked, controlled trial was conducted in 80 patients with impending recurrent pterygium. Patients were randomized i...
Saved in:
Main Authors: | Kaevalin Lekhanont, Thanikan Patarakittam, Prakairut Thongphiew, Olan Suwan-Apichon, Prut Hanutsaha |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/15001 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: Preliminary results
by: Orapin Enkvetchakul, et al.
Published: (2018) -
The effect of subconjunctival bevacizumab on angiogenesis in rabbit model
by: Nurwasis, Nurwasis, et al.
Published: (2019) -
Progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum
by: Kaevalin Lekhanont, et al.
Published: (2018) -
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
by: D. A. Reardon, et al.
Published: (2018) -
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
by: Suthasinee Kumluang, et al.
Published: (2019)